Acadia Pharmaceuticals reported $-33136000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
ALKERMES ALKS:US USD -41044000 25.98M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Aptinyx Inc APTX:US USD -14557000 2.45M
Biogen BIIB:US USD 992.8M 82.9M
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Cara Therapeutics CARA:US USD -23783000 19.37M
Corcept Therapeutics CORT:US USD 32.13M 581K
Cytokinetics CYTK:US USD -107033000 97.57M
Eisai 4523:JP JPY 7.71B 9.53B
Eli Lilly And LLY:US USD 2.31B 308.9M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Intra Cellular Therapies ITCI:US USD -55459000 32.29M
Johnson & Johnson JNJ:US USD 7.81B 876M
Marinus Pharmaceuticals MRNS:US USD -29941000 6.73M
Moderna Inc MRNA:US USD 1.28B 1.24B
Neurocrine Biosciences NBIX:US USD 91.8M 33.2M
Pfizer PFE:US USD 10.52B 2.78B
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Seattle Genetics SGEN:US USD -175213000 59.32M
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M
YTE INCY:US USD 134.94M 141.85M